Results 171 to 180 of about 100,300 (318)

Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel Disease: The RESTORE SVD China Randomized Trial.

JACC: Cardiovascular Interventions, 2018
Yida Tang, S. Qiao, X. Su, Yundai Chen, Zening Jin, Hui Chen, Biao Xu, X. Kong, Wenyue Pang, Yong Liu, Zaixin Yu, Xue Li, Hui Li, Yanyan Zhao, Yang Wang, Wei Li, Jian Tian, C. Guan, Bo Xu, R. Gao   +19 more
semanticscholar   +1 more source

Drug-eluting stents : Insights into safety and indications

Annals of Saudi Medicine, 2008
Currently, more than 4 million patients receive drug-eluting stents worldwide. Despite recent studies and editorials that have stirred controversy and generated tremendous publicity in the lay press related to the safety of drug-eluting stents for the ...
Hassan Walid
doaj  

Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results

Medical Devices: Evidence and Research, 2014
Guillaume Schurtz,1,2 Cédric Delhaye,1 Christopher Hurt,1,2 Henri Thieuleux,1,2 Gilles Lemesle1–3 1Centre Hémodynamique et Unité des Soins Intensifs de Cardiologie, Hôpital Cardiologique, Centre Hospitalier Ré ...
Schurtz G, Delhaye C, Hurt C, Thieuleux H, Lemesle G   +4 more
doaj  

Drug-Eluting or Bare-Metal Stents for ST Elevation Myocardial Infarction Can Observational Data Balance the Risk Benefit Equation? [PDF]

, 2008
Donald E. Cutlip
openalex   +1 more source

Cardiovascular and bleeding risks of inactive cancer in patients with acute myocardial infarction who received primary percutaneous coronary intervention using drug-eluting stent and dual/triple antithrombotic therapy [PDF]

, 2022
Hiroya Hayashi, Yu Kataoka, Kota Murai, Kenichiro Sawada, Takamasa Iwai, Hideo Matama, Satoshi Honda, Masashi Fujino, Shuichi Yoneda, Kensuke Takagi, Fumiyuki Otsuka, Yasuhide Asaumi, Yasuhiro Izumiya, Daiju Fukuda, Teruo Noguchi   +14 more
openalex   +1 more source

Final 3-Year Outcome of a Randomized Trial Comparing Second-Generation Drug-Eluting Stents Using Either Biodegradable Polymer or Durable Polymer: NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-Eluting Stent Trial

Circulation. Cardiovascular Interventions, 2015
M. Natsuaki, K. Kozuma, T. Morimoto, K. Kadota, T. Muramatsu, Y. Nakagawa, T. Akasaka, K. Igarashi, K. Tanabe, Y. Morino, T. Ishikawa, H. Nishikawa, M. Awata, M. Abe, H. Okada, Y. Takatsu, Nobuhiko Ogata, Kazuo Kimura, K. Urasawa, Y. Tarutani, N. Shiode, Takeshi Kimura   +21 more
semanticscholar   +1 more source

Drug-Eluting Stent Use in Percutaneous Coronary Interventions-A Narrative Review. [PDF]

J Clin Med
Arh R, Balevski I, Granda S, Bevc S.
europepmc   +1 more source

Immunosuppressive therapy and tolerance of organ allografts [PDF]

, 2008
Starzl, TE
core   +1 more source

Trial sequential analysis of studies comparing the frequency of target-vessel revascularization with drug-coated balloons as compared with second-generation drug-eluting stents in coronary in-stent restenosis: Have we generated enough evidence in the field?

, 2019
Ashish Kumar, Mariam Shariff
openalex   +1 more source

Recurrent cardiac drug-eluting stent thrombosis due to antiphospholipid syndrome: a case report. [PDF]

AME Case Rep
Lin KK, Wine YY, Aye ST.
europepmc   +1 more source